Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

333 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incorporating immune checkpoint inhibitors in epithelial ovarian cancer.
Bogani G, Moore KN, Ray-Coquard I, Lorusso D, Matulonis UA, Ledermann JA, González-Martín A, Kurtz JE, Pujade-Lauraine E, Scambia G, Caruso G, Raspagliesi F, Colombo N, Monk BJ. Bogani G, et al. Among authors: gonzalez martin a. Gynecol Oncol. 2025 Jan 6;193:30-40. doi: 10.1016/j.ygyno.2024.12.011. Online ahead of print. Gynecol Oncol. 2025. PMID: 39764856 Review.
Predicting benefit from PARP inhibitors using deep learning on H&E-stained ovarian cancer slides.
Marmé F, Krieghoff-Henning EI, Kiehl L, Wies C, Hauke J, Hahnen E, Harter P, Schouten PC, Brodkorb T, Kayali M, Heitz F, Zamagni C, González-Martin A, Treilleux I, Kommoss S, Prieske K, Gaiser T, Fröhling S, Ray-Coquard I, Pujade-Lauraine E, Brinker TJ. Marmé F, et al. Among authors: gonzalez martin a. Eur J Cancer. 2024 Dec 26;216:115199. doi: 10.1016/j.ejca.2024.115199. Online ahead of print. Eur J Cancer. 2024. PMID: 39742559 Free article.
Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-ov80).
Lee JY, Tan D, Ray-Coquard I, Lee JB, Kim BG, Van Nieuwenhuysen E, Huang RY, Tse KY, González-Martin A, Scott C, Hasegawa K, Wilkinson K, Yang EY, Lheureux S, Kristeleit R. Lee JY, et al. Among authors: gonzalez martin a. J Gynecol Oncol. 2024 Dec 16. doi: 10.3802/jgo.2025.36.e51. Online ahead of print. J Gynecol Oncol. 2024. PMID: 39710508 Free article.
Ancient genomics support deep divergence between Eastern and Western Mediterranean Indo-European languages.
Yediay FE, Kroonen G, Sabatini S, Frei KM, Frank AB, Pinotti T, Wigman A, Thorsø R, Vimala T, McColl H, Moutafi I, Altinkaya I, Ramsøe A, Gaunitz C, Renaud G, Martin AM, Demeter F, Scorrano G, Canci A, Fischer P, Duyar I, Serhal C, Varzari A, Türkteki M, O'Shea J, Rahmstorf L, Polat G, Atamtürk D, Vinner L, Omura S, Matsumura K, Cao J, Valeur Seersholm F, Morillo Leon JM, Voutsaki S, Orgeolet R, Burke B, Herrmann NP, Recchia G, Corazza S, Borgna E, Sampò MC, Trucco F, Pando AP, Schjellerup Jørkov ML, Courtaud P, Peake R, Bao JFG, Parditka G, Stenderup J, Sjögren KG, Staring J, Olsen L, Deyneko IV, Pálfi G, Aldana PML, Burns B, Paja L, Mühlenbock C, Cavazzuti C, Cazzella A, Lagia A, Lambrinoudakis V, Kolonas L, Rambach J, Sava E, Agulnikov S, Castañeda Fernández V, Broné M, Peña Romo V, Molina González F, Cámara Serrano JA, Jiménez Brobeil S, Nájera Molino T, Rodríguez Ariza MO, Galán Saulnier C, González Martín A, Cauwe N, Mordant C, Roscio M, Staniaszek L, Tafuri MA, Yıldırım T, Salzani L, Sand Korneliussen T, Moreno-Mayar JV, Allentoft ME, Sikora M, Nielsen R, Kristiansen K, Willerslev E. Yediay FE, et al. Among authors: gonzalez martin a. bioRxiv [Preprint]. 2024 Dec 2:2024.12.02.626332. doi: 10.1101/2024.12.02.626332. bioRxiv. 2024. PMID: 39677618 Free PMC article. Preprint.
Can Morphology and Immune Infiltration Predict the Homologous Recombination Deficiency Status in Newly Diagnosed High-Grade Serous Ovarian Carcinoma?
Kime A, Bataillon G, Treilleux I, Callens C, Selle F, Heitz F, Cinieri S, González-Martin A, Schauer C, Lindahl G, Parma G, Vergote I, Matsumoto T, Blonz C, Canzler U, Mosconi AM, Guerra Alía EM, Pujade-Lauraine E, Genestie C, Ray-Coquard I, Just PA. Kime A, et al. Among authors: gonzalez martin a. Arch Pathol Lab Med. 2024 Dec 9. doi: 10.5858/arpa.2024-0081-OA. Online ahead of print. Arch Pathol Lab Med. 2024. PMID: 39648143 Free article.
Use of individualized starting dose and niraparib hematologic adverse event management costs in ovarian cancer.
Graybill WS, Vergote I, Pothuri B, Anttila M, O'Malley DM, Lorusso D, Haggerty AF, Fabbro M, Chan JK, Heitz F, Willmott LJ, Bruchim I, Zhuo Y, Estévez-García P, Monk BJ, Denys H, Knudsen A, Tinker AV, Sánchez LM, Provencher D, Barretina-Ginesta MP, Hartman J, Booth DV, González-Martín A. Graybill WS, et al. Among authors: gonzalez martin a. J Comp Eff Res. 2025 Jan;14(1):e240133. doi: 10.57264/cer-2024-0133. Epub 2024 Dec 6. J Comp Eff Res. 2025. PMID: 39641537 Free PMC article.
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.
Harter P, Marth C, Mouret-Reynier MA, Cropet C, Lorusso D, Guerra-Alía EM, Matsumoto T, Vergote I, Colombo N, Mäenpää J, Lebreton C, de Gregorio N, Mosconi AM, Rubio-Pérez MJ, Bourgeois H, Fasching PA, Cecere SC, Hardy-Bessard AC, Denschlag D, de Percin S, Hanker L, Favier L, Bauerschlag D, Desauw C, Hillemanns P, Largillier R, Sehouli J, Grenier J, Pujade-Lauraine E, Ray-Coquard I; PAOLA-1/ENGOT-ov25 investigators. Harter P, et al. Ann Oncol. 2024 Nov 9:S0923-7534(24)04907-X. doi: 10.1016/j.annonc.2024.10.828. Online ahead of print. Ann Oncol. 2024. PMID: 39528049 Free article.
How long is long enough? An international survey exploring practice variations on the recommended duration of maintenance therapy with PARP inhibitors in patients with platinum sensitive recurrent ovarian cancer and long-term outcomes.
Haggstrom L, Lee YC, Scott C, Harter P, Woelber L, Ledermann J, Gourley C, McNeish IA, Amant F, Ray-Coquard I, Leary A, Oza AM, Tinker A, González Martin A, Cecere SC, Pignata S, Colombo N, Yoshida H, Marth C, Rosengarten O, Moore KN, Gómez-García EM, Tan D, Friedlander ML. Haggstrom L, et al. Among authors: gonzalez martin a. Int J Gynecol Cancer. 2024 Dec 2;34(12):1932-1939. doi: 10.1136/ijgc-2024-005976. Int J Gynecol Cancer. 2024. PMID: 39438068
333 results